Cryoport Inc logo

CYRX - Cryoport Inc Share Price

$33.68 -0.6  -1.8%

Last Trade - 10/07/20

Sector
Industrials
Size
Mid Cap
Market Cap £1.02bn
Enterprise Value £939.8m
Revenue £29.4m
Position in Universe 2115th / 6339
Bullish
Bearish
Unlock CYRX Revenue
Momentum
Relative Strength (%)
1m +21.4%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -3.58%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
3.94 5.88 6.12 12.0 19.6 33.9 42.6 62.0 +53.9%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the three months ended 31 March 2020, CryoPort Inc revenues increased 47% to $9.8M. Net loss increased 65% to $3.9M. Revenues reflect Global Bioservices segment increase from $0K to $1.3M, Europe & Middle East & Africa (EMEA) segment increase from $364K to $1.9M, Americas segment increase of 25% to $7.7M. Higher net loss reflects Engineering and development - Balancing increase from $418K to $1.6M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for CYRX
Graphical History

Revenue

CYRX Revenue Unlock CYRX Revenue

Net Income

CYRX Net Income Unlock CYRX Revenue

Normalised EPS

CYRX Normalised EPS Unlock CYRX Revenue

PE Ratio Range

CYRX PE Ratio Range Unlock CYRX Revenue

Dividend Yield Range

CYRX Dividend Yield Range Unlock CYRX Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
CYRX EPS Forecasts Unlock CYRX Revenue
Profile Summary

Cryoport, Inc. (Cryoport) is a provider of cryogenic logistics solutions to the life sciences industry through its purpose-built packaging, information technology and specialized cold chain logistics expertise. The Company provides logistics solutions for biologic materials, such as immunotherapies, stem cells, chimeric antigen receptors (CAR)-T cells, and reproductive cells for clients. The Company's Cryoport Express Solution includes a cloud-based logistics operating platform, which is branded as the Cryoportal. The Company's Cryoport Express Solutions are made up of the Cryoportal software platform, Cryoport Express Shippers, Cryoport Express Smart Pak data loggers and its life sciences cold chain logistics expertise. The Cryoportal is used by the Company, its clients and its business partners to automate the entry of orders, prepare customs documentation, and to facilitate status and location monitoring of shipped orders while in transit.

Directors
Last Annual December 31st, 2019
Last Interim March 31st, 2020
Incorporated May 25, 1990
Public Since July 24, 2015
No. of Shareholders: 198
No. of Employees: 105
Sector Industrials
Industry Freight & Logistics Services
Index Nasdaq Composite ,
Exchange NASDAQ Capital Market
Shares in Issue 38,101,393
Free Float (0.0%)
Eligible for
ISAs
SIPPs
CYRX Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for CYRX
Upcoming Events for CYRX
Frequently Asked Questions for Cryoport Inc
What is the Cryoport Inc share price?

As of 10/07/20, shares in Cryoport Inc are trading at $33.68, giving the company a market capitalisation of £1.02bn. This share price information is delayed by 15 minutes.

How has the Cryoport Inc share price performed this year?

Shares in Cryoport Inc are currently trading at $33.68 and the price has moved by 71.92% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Cryoport Inc price has moved by 64.38% over the past year.

What are the analyst and broker recommendations for Cryoport Inc?

Of the analysts with advisory recommendations for Cryoport Inc, there are there are currently 3 "buy" , 0 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Cryoport Inc is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Cryoport Inc next release its financial results?

Cryoport Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-03-31
What is the Cryoport Inc dividend yield?

Cryoport Inc does not currently pay a dividend.

Does Cryoport Inc pay a dividend?

Cryoport Inc does not currently pay a dividend.

When does Cryoport Inc next pay dividends?

Cryoport Inc does not currently pay a dividend.

How do I buy Cryoport Inc shares?

To buy shares in Cryoport Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Cryoport Inc?

Shares in Cryoport Inc are currently trading at $33.68, giving the company a market capitalisation of £1.02bn.

Where are Cryoport Inc shares listed? Where are Cryoport Inc shares listed?

Here are the trading details for Cryoport Inc:

Country of listing: United States
Exchange: NAQ
Ticker Symbol: CYRX
What kind of share is Cryoport Inc?

Based on an overall assessment of its quality, value and momentum, Cryoport Inc is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Cryoport Inc share price forecast 2020?

Shares in Cryoport Inc are currently priced at $33.68. At that level they are trading at 23.66% premium to the analyst consensus target price of 0.00.

Analysts covering Cryoport Inc currently have a consensus Earnings Per Share (EPS) forecast of -0.353 for the next financial year.

How can I tell whether the Cryoport Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cryoport Inc. Over the past six months, the relative strength of its shares against the market has been 0.107k%. At the current price of $33.68, shares in Cryoport Inc are trading at 80.14% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Cryoport Inc PE Ratio?

We were not able to find PE ratio data for Cryoport Inc.

Who are the key directors of Cryoport Inc?

Cryoport Inc's management team is headed by:

Robert Stefanovich - CFO
Jerrell Shelton - CHM
Edward Zecchini - IND
Ramkumar Mandalam - IND
Richard Berman - LED
Robert Hariri - IND
Daniel Hancock - DRC
Who are the major shareholders of Cryoport Inc?

Here are the top five shareholders of Cryoport Inc based on the size of their shareholding:

Fred Alger Management, Inc. Investment Advisor/Hedge Fund
Percentage owned: 12.4% (4.72m shares)
Alger Small Cap Focus Fund Mutual Fund
Percentage owned: 10.08% (3.84m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 5.89% (2.25m shares)
Victory Capital Management Inc. Investment Advisor/Hedge Fund
Percentage owned: 5.86% (2.23m shares)
The Vanguard Group, Inc. Investment Advisor/Hedge Fund
Percentage owned: 5.04% (1.92m shares)
Similar to CYRX
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.